Interstitial Lung Disease News

From 2007 to 2018, hospitalizations for respiratory failure increased, while respiratory failure-related mortality declined among individuals with sarcoidosis, according to data published in Chest.

A speaker at the PFF Summit highlighted recent trials and therapeutic updates for progressive fibrosing interstitial lung disease.

Hospitalization rates in patients with sarcoidosis in Canada decreased over the past 20 years, researchers reported in the Annals of the American Thoracic Society.

Small airways loss appears to be an important aspect in the pathophysiology of fibrotic pulmonary sarcoidosis, researchers concluded in a new Chest study.

In the absence of curative or disease-altering therapies, patients with sarcoidosis value interventions that improve their quality of life over those for function or even survival, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Individuals with preexisting respiratory diseases, including asthma and COPD, had a modestly increased risk for severe COVID-19 infection, researchers reported in The Lancet Respiratory Medicine.

The incidence of scleritis declined by about a third in the United Kingdom between 1997 and 2018, according to data published in Arthritis & Rheumatology.

Black patients who presented with cutaneous sarcoidosis had an increased risk for systemic disease and cardiovascular involvement compared with other racial groups, according to findings presented at Maui Derm for Dermatologists.

Patricia W. Finn, MD, is a physician scientist focusing on the microbiome and immune-mediated pulmonary diseases. In this episode, she shares her experiences in health care, effects of the pandemic and the importance of personal care.

Mortality due to COVID-19 was higher in patients with preexisting fibrotic idiopathic interstitial lung disease compared with other interstitial lung diseases, researchers reported in a new study.